Acute Response in vivo of a Fiber-Optic Sensor for Continuous Glucose Monitoring from Canine Studies on Point Accuracy

The objective of this study was to evaluate the acute response of Sencil™, a fiber-optic sensor, in point accuracy for glucose monitoring in vivo on healthy dogs under anesthesia. A total of four dogs with clinically normal glycemia were implanted with one sensor each in the chest region to measure the interstitial glucose concentration during the ovariohysterectomy procedure. The data was acquired every 10 seconds after initiation, and was compared to the concentration of venous plasma glucose sampled during the surgery procedures for accuracy of agreement analysis. In the four trials with a range of 71–297 mg/dL plasma glucose, the collected 21 pairs of ISF readings from the Sencil™ and the plasma reference showed superior dispersion of residue values than the conventional system, and a linear correlation (the Pearson correlation coefficient is 0.9288 and the y-intercept is 14.22 mg/dL). The MAD (17.6 mg/dL) and RMAD (16.16%) of Sencil™ measurements were in the comparable range of the conventional system. The Clarke error grid analysis indicated that 100% of the paired points were in the clinically acceptable zone A (61.9%) and B (38.1%).

[1]  W. Clarke.  The original Clarke Error Grid Analysis (EGA). , 2005, Diabetes technology & therapeutics.

[2]  Boris Kovatchev,et al.  A Critical Appraisal of the Continuous Glucose–Error Grid Analysis , 2007, Diabetes Care.

[3]  G M Steil,et al.  Can interstitial glucose assessment replace blood glucose measurements? , 2000, Diabetes technology & therapeutics.

[4]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[5]  John J Mastrototaro,et al.  Metabolic modelling and the closed-loop insulin delivery problem. , 2006, Diabetes research and clinical practice.

[6]  John J Mastrototaro,et al.  Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. , 1999, American journal of physiology. Endocrinology and metabolism.

[7]  Manjot Kaur,et al.  Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. , 2010, Biomaterials.

[8]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[9]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[10]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[11]  L. Landau,et al.  THE PROPAGATION OF LIGHT , 1975 .

[12]  N. Gretz,et al.  Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensors in rats. , 2007, Biosensors & bioelectronics.

[13]  R. Potts,et al.  Physiological differences between interstitial glucose and blood glucose measured in human subjects. , 2003, Diabetes care.

[14]  Laura Marcu,et al.  Design and fabrication of disposable percutaneous chemical sensors , 2005, SPIE BiOS.

[15]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[16]  N. Woodhouse.  The Propagation of Light , 2003 .

[17]  P. Böhme,et al.  Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. , 2003, Diabetes care.

[18]  H. S. Wolff,et al.  iRun: Horizontal and Vertical Shape of a Region-Based Graph Compression , 2022, Sensors.

[19]  G. S. Wilson,et al.  Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. , 1991, Analytical chemistry.

[20]  R O Potts,et al.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. , 1999, Diabetes care.

[21]  C. Saudek,et al.  Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. , 2003, Diabetes.

[22]  G. Steil,et al.  The role of the independent variable to glucose sensor calibration. , 2003, Diabetes technology & therapeutics.

[23]  Laura Marcu,et al.  Percutaneous fiber-optic sensor for chronic glucose monitoring in vivo. , 2008, Biosensors & bioelectronics.

[24]  J. Santerre,et al.  Neutrophil-mediated degradation of segmented polyurethanes. , 1995, Biomaterials.

[25]  M. Shichiri,et al.  Enhanced, simplified glucose sensors: long-term clinical application of wearable artificial endocrine pancreas. , 1998, Artificial organs.

[26]  J. Pickup.  In Vivo Glucose Monitoring: Sense and Sensorbility , 1993, Diabetes Care.

[27]  G. S. Wilson,et al.  Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. , 2000, American journal of physiology. Endocrinology and metabolism.